Avonex pen 30 MCG/0.5 ML (4PK)s
Ended Awarded
- Contract number
- SPE2DB26FDU92
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,361
Award facts
- Contract value 100% obligated
- $11,361.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of AVONEX Pen 30 mcg/0.5 ml in a four-pack configuration, valued at $11,361.30 under a firm fixed-price contract with no set-aside designation. This delivery order represents a competitive procurement action and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 30, 2025. The contract award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal contract awards predominantly with the Defense Logistics Agency and its Medical Supply Chain, supplying a broad range of pharmaceutical products, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. AVONEX Pen, used primarily in the treatment of multiple sclerosis, represents one of the specialized pharmaceutical products within the company's federal medical procurement capabilities. This delivery order exemplifies the routine pharmaceutical supply operations conducted under the SPE2DX vehicle, which enables AmerisourceBergen to fulfill federal medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB26FDU92?
SPE2DB26FDU92 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FDU92 worth?
The government has obligated $11,361 on SPE2DB26FDU92.
Is contract SPE2DB26FDU92 an order under another contract?
Yes. SPE2DB26FDU92 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB26FDU92 competed?
The extent of competition for SPE2DB26FDU92 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award